Characteristics of 9194 patients with left ventricular hypertrophy: the LIFE study. Losartan Intervention For Endpoint Reduction in Hypertension.
Dahlöf B, Devereux RB, Julius S, Kjeldsen SE, Beevers G, de Faire U, Fyhrquist F, Hedner T, Ibsen H, Kristianson K, Lederballe-Pedersen O, Lindholm LH, Nieminen MS, Omvik P, Oparil S, Wedel H.
Dahlöf B, et al. Among authors: hedner t.
Hypertension. 1998 Dec;32(6):989-97. doi: 10.1161/01.hyp.32.6.989.
Hypertension. 1998.
PMID: 9856962
Clinical Trial.